1
Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients – SENRI Trial
Condition(s):Colorectal CancerLast Updated:February 26, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:February 26, 2021Completed
Condition(s):Peritonitis; Postoperative ComplicationsLast Updated:July 21, 2011Withdrawn
Condition(s):Colorectal CancerLast Updated:October 26, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.